Skip to main content

Find Clinical Trials

Home
Conditions
Immune Thrombocytopenia

Clinical trial condition

Immune Thrombocytopenia

Explore clinical trials studying Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

94 public trials 33 recruiting studies

Refine in advanced search Browse all conditions

Immune Thrombocytopenia trial results

Completed

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

NCT02859909

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Investigational site # 3597 Pleven, Bulgaria

Investigational site # 3593 Plovdiv, Bulgaria

Investigational site # 3598 Sofia, Bulgaria

Investigational site # 3591 Sofia, Bulgaria

View all 22 locations

View Trial Details

Completed

Safety and Efficacy of Eltrombopag at Escalated Doses

NCT01880047

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Weill Cornell Medicine New York, United States

View Trial Details

Completed

A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

NCT03603132

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: The third xiangya hospital Hospital,of central south university Changsha, Hunan, China

View Trial Details

Completed

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

NCT00902018

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

NCT01568333

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Shandong University Qilu hospital Jinan, Shandong, China

View Trial Details

Completed

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

NCT03229746

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Assiut university hospital Asyut, Egypt

View Trial Details

Completed

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

NCT01438840

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Adelaide, Australia

Bedford Park, Australia

Antwerp, Belgium

Plovdiv, Bulgaria

View all 25 locations

View Trial Details

Completed

Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)

NCT02287649

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

The Study of Different Dose Rituximab in the Treatment of ITP

NCT03258866

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu hospital, Shandong University Jinan, Shandong, China

View Trial Details

Completed

Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

NCT01727999

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Stanford University Stanford, California, United States

Weill Medical College, Cornell University New York, United States

View Trial Details